Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Soriano, V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 320 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nunez, M; de Requena, DG; Gallego, L; Jimenez-Nacher, I; Gonzalez-Lahoz, J; Soriano, V
      Higher efavirenz plasma levels correlate with development of insomnia

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Barreiro, P; Oller, V; Soriano, V; Nunez, M; Rodriguez-Rosado, R; Gonzalez-Lahoz, J
      Performance of a quadruple combination including nelfinavir plus efavirenzin naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Soriano, V; Barreiro, P; de Mendoza, C; Dona, C; Gonzalez-Lahoz, J
      Monthly cyclic therapy in heavily pretreated HIV-infected patients

      AIDS PATIENT CARE AND STDS
    6. Soriano, V; Martin-Carbonero, L; Garcia-Samaniego, J; Puoti, M
      Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus

      CLINICAL INFECTIOUS DISEASES
    7. Nunez, M; Rodriguez-Rosado, R; Soriano, V
      Intensification of antiretroviral therapy

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    8. Cilla, G; Rodes, B; Perez-Trallero, E; Arrizabalaga, J; Soriano, V
      Molecular evidence of homosexual transmission of HIV type 2 in Spain

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    9. Martin-Carbonero, L; Soriano, V; Valencia, E; Garcia-Samaniego, J; Lopez, M; Gonzalez-Lahoz, J
      Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    10. Luk, KC; Kaptue, L; Zekeng, L; Soriano, V; Gurtler, L; Devare, SG; Schochetman, G; Hackett, J
      Naturally occurring sequence polymorphisms within HIV type 1 group O protease

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    11. Soriano, V
      Sequencing antiretroviral drugs

      AIDS
    12. Miller, V; Vandamme, AM; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait-Khaled, M; Boucher, C; Brun-Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; Broekhuizen, A; Bush-Donovan, C; Camacho, R; Carlier, H; Clavel, F; Clotet, B; Clumeck, N; Colebunders, R; De Clerq, K; De Jaegher, JJ; De Schrijver, G; De Smet, K; Hall, W; Harrigan, R; Hatzakis, A; Hellmann, N; Hoetelmans, R; Holtzer, C; Katlama, C; Larder, D; Loriaux, E; McCreedy, B; Mulcahy, F; Opravil, M; Phillips, A; Ruiz, N; Shulse, E; Sonnerborg, A; Soriano, V; Steel, H; Vella, S; Williams, A
      Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting

      AIDS
    13. Gallego, O; Ruiz, L; Vallejo, A; Ferrer, E; Rubio, A; Clotet, B; Leal, M; Soriano, V
      Changes in the rate of genotypic resistance to antiretroviral drugs in Spain

      AIDS
    14. Gallego, O; de Mendoza, C; Perez-Elias, MJ; Guardiola, JM; Pedreira, J; Dalmau, D; Gonzalez, J; Moreno, A; Arribas, JR; Rubio, A; Garcia-Arata, I; Leal, M; Domingo, P; Soriano, V
      Drug resistance in patients experiencing early virological failure under atriple combination including indinavir

      AIDS
    15. Machuca, A; Rodes, B; Soriano, V
      The effect of antiretroviral therapy on HTLV infection

      VIRUS RESEARCH
    16. Rodriguez-Rosado, R; Perez-Olmeda, M; Garcia-Samaniego, J; Soriano, V
      Management of hepatitis C in HIV-infected persons

      ANTIVIRAL RESEARCH
    17. de Mendoza, C; Lu, W; Machuca, A; Sainz, M; Castilla, J; Soriano, V
      Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays

      JOURNAL OF MEDICAL VIROLOGY
    18. Perez-Olmeda, M; Del Romero, J; Rubio, A; Ruiz, L; Rodriguez, C; Leal, M; Clotet, B; Soriano, V
      Primary HIV-1 drug resistance in spain before and after the introduction of protease inhibitors

      JOURNAL OF MEDICAL VIROLOGY
    19. Soriano, V; Martin, JC; Gonzalez-Lahoz, J
      HIV-1 progression in hepatitis-C-infected drug users

      LANCET
    20. Barreiro, P; Soriano, V; Gonzalez-Lahoz, J
      Prevention of nevirapine-associated rash

      LANCET
    21. Holguin, A; Aracil, B; Alvarez, A; Barros, C; Soriano, V
      Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances ofthe AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5

      JOURNAL OF CLINICAL MICROBIOLOGY
    22. Swanson, P; Soriano, V; Devare, SG; Hackett, J
      Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) andgroup O: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR version 1.5, andQuantiplex HIV-1 RNA version 3.0

      JOURNAL OF CLINICAL MICROBIOLOGY
    23. Gonzalez-Castillo, J; Blanco, F; Soriano, V; Barreiro, P; Bravo, MC; Jimenez-Nacher, I; Gonzalez-Lahoz, J
      Opportunistic events shortly after beginning HAART in HIV-infected patients

      MEDICINA CLINICA
    24. Lana, R; Nunez, M; Mendoza, JL; Soriano, V
      Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy

      MEDICINA CLINICA
    25. Diaz, B; Nunez, M; Soriano, V
      Acute hepatitis B in a previously vaccined patient infected by the human immunodeficiency virus

      MEDICINA CLINICA
    26. Garcia-Samaniego, J; Rodriguez, M; Berenguer, J; Rodriguez-Rosado, R; Carbo, J; Asensi, V; Soriano, V
      Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    27. Gallego, O; Briones, C; Corral, A; Soriano, V
      Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    28. Barreiro, P; Soriano, V; Oller, V; Gonzalez-Lahoz, J
      Potent activity but limited tolerance of ritonavir plus indinavir in salvage interventions

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    29. Shanmugam, V; Switzer, WM; Nkengasong, JN; Garcia-Lerma, G; Green, TA; Ekpini, E; Sassan-Morokro, M; Antunes, F; Manshino, K; Soriano, V; Wiktor, SZ; Heneine, W
      Lower HIV-2 plasma viral loads may explain differences between the naturalhistories of HIV-1 and HIV-2 infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    30. Machuca, A; Soriano, V
      In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    31. Briones, C; Soriano, V; Dona, C; Barreiro, P; Gonzalez-Lahoz, J
      Can early failure with nevirapine be rescued with efavirenz?

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    32. de Mendoza, C; Soriano, V; Briones, C; Gallego, O; Barreiro, P; Alvarez, A; Gonzalez-Lahoz, J
      Emergence of zidovudine resistance in HIV-Infected patients receiving stavudine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    33. Machuca, A; Tuset, C; Soriano, V; Caballero, E; Aguilera, A; de Lejarazu, RO
      Prevalence of HTLV infection in pregnant women in Spain

      SEXUALLY TRANSMITTED INFECTIONS
    34. Enriquez, J; Gallego, A; Torras, X; Perez-Olmeda, T; Diago, M; Soriano, V; Lujan, MS; Garcia-Samaniego, J
      Retreatment for 24 vs 48 weeks with interferon-alpha 2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon alone

      JOURNAL OF VIRAL HEPATITIS
    35. Barreiro, P; Soriano, V; Cabello, N; Gonzalez-Lahoz, J
      Is there a role for indinavir twice-daily in clinical practice?

      CLINICAL MICROBIOLOGY AND INFECTION
    36. Martin-Carbonero, L; Barreiro, P; Soriano, V; Gonzalez-Lahoz, J
      Tolerability of Abacavir in the clinical setting

      CLINICAL MICROBIOLOGY AND INFECTION
    37. de Mendoza, C; Soriano, V; Perez-Olmeda, M; Rodriguez-Rosado, R; Gonzalez-Lahoz, J
      Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients

      JOURNAL OF HUMAN VIROLOGY
    38. Nunez, M; Soriano, V
      Salvage therapy for HIV infection: When and how

      AIDS PATIENT CARE AND STDS
    39. Soriano, V; Barreiro, P; Gonzalez-Lahoz, J
      Induction-maintenance (5 -> 3 drugs) in HIV-infected patients with high viral load

      AIDS PATIENT CARE AND STDS
    40. Holguin, A; Rodes, B; Soriano, V
      Recombinant human immunodeficiency viruses type 1 circulating in Spain

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    41. Holguin, A; Rodes, B; Soriano, V
      Protease gene analysis of HIV type 1 non-B subtypes in Spain

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    42. Nunez, M; Machuca, A; Soriano, V; Podzamczer, D; Gonzalez-Lahoz, J
      Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin

      AIDS
    43. Barreiro, P; Soriano, V; Blanco, F; Casimiro, C; de la Cruz, JJ; Gonzalez-Lahoz, J
      Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

      AIDS
    44. Puig, T; Perez-Olmeda, M; Rubio, A; Ruiz, L; Briones, C; Franco, JM; Gomez-Cano, M; Stuyver, L; Zamora, L; Alvarez, C; Leal, M; Clotet, B; Soriano, V
      Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

      AIDS
    45. Soriano, V; Dona, C; Rodriguez-Rosado, R; Barreiro, P; Gonzalez-Lahoz, J
      Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy

      AIDS
    46. Barreiro, P; de Mendoza, C; Soriano, V; Gonzalez-Lahoz, J
      Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy

      AIDS
    47. Perez-Olmeda, M; Garcia-Samaniego, J; Soriano, V
      Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy

      AIDS
    48. Soriano, V; Rodriguez-Rosado, R; Perez-Olmeda, M; Romero, M; Garcia-Samaniego, J
      Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients

      AIDS
    49. Barreiro, P; Soriano, V; Casas, E; Estrada, V; Tellez, MJ; Hoetelmans, R; de Requena, DG; Jimenez-Nacher, I; Gonzalez-Lahoz, J
      Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

      AIDS
    50. Pieniazek, D; Rayfield, M; Hu, DJ; Nkengasong, J; Wiktor, SZ; Downing, R; Biryahwaho, B; Mastro, T; Tanuri, A; Soriano, V; Lal, R; Dondero, T
      Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide

      AIDS
    51. Briones, C; Soriano, V; Gonzalez-Lahoz, J
      Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure

      AIDS
    52. Soriano, V; Dona, C; Barreiro, P; Gonzalez-Lahoz, J
      Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?

      AIDS
    53. Mas, A; Parera, M; Briones, C; Soriano, V; Martinez, MA; Domingo, E; Menendez-Arias, L
      Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance

      EMBO JOURNAL
    54. Briones, C; Mas, A; Gomez-Mariano, G; Altisent, C; Menedez-Arias, L; Soriano, V; Domingo, E
      Dynamics of dominance of a dipeptide insertion in reverse transcriptase ofHIV-1 from patients subjected to prolonged therapy

      VIRUS RESEARCH
    55. Soriano, V; Gomes, P; Heneine, W; Holguin, A; Doruana, M; Antunes, R; Mansinho, K; Switzer, WM; Araujo, C; Shanmugam, V; Lourenco, H; Gonzalez-Lahoz, J; Antunes, F
      Human immunodeficiency virus type 2 (HIV-2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load

      JOURNAL OF MEDICAL VIROLOGY
    56. Rodes, B; Holguin, A; Soriano, V; Dourana, M; Mansinho, K; Antunes, F; Gonzalez-Lahoz, J
      Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy

      JOURNAL OF CLINICAL MICROBIOLOGY
    57. Lerma, JGG; Soriano, V; Mas, A; Quinones-Mateu, ME; Arts, EJ; Heneine, W
      Quantitation of human immunodeficiency virus type 1 group O load in plasmaby measuring reverse transcriptase activity

      JOURNAL OF CLINICAL MICROBIOLOGY
    58. Dona, C; Soriano, V; Barreiro, P; Jimenez-Nacher, I; Gonzalez-Lahoz, J
      Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program

      MEDICINA CLINICA
    59. Nunez, M; Soriano, V
      Cancer and HIV in the combined therapy era

      MEDICINA CLINICA
    60. Martin, JC; Fernandez, P; Soriano, V; Martinez, P; Gonzalez-Lahoz, J
      Viral load and CD4+lymphocyte count in the highly active antiretroviral therapy era

      MEDICINA CLINICA
    61. Holguin, A; Soriano, V
      Origin and evolution of human immunodeficiency virus

      MEDICINA CLINICA
    62. del Amo, J; Perez-Hoyos, S; Aguado, IH; Muga, R; Egea, JM; Clotet, B; Tor, J; Ruiz, I; Tussell, J; Lorenzo, JI; del Romero, J; Barrasa, A; Rodriguez, C; Castilla, J; Garcia, S; Diez, M; Soriano, V; del Amo, J; Avino, J; Aracil, JG; Garcia, M; Brugal, T; Cayla, J; de Olaya, PG
      AIDS incubation period in Spain before highly active antiretreviral therapy

      MEDICINA CLINICA
    63. Rodriguez-Rosado, R; Soriano, V
      Intensified anti-retroviral therapy

      REVISTA CLINICA ESPANOLA
    64. Soriano, V; Rodriguez-Rosado, R; Lahoz, JG
      Rescue anti-retroviral therapy

      REVISTA CLINICA ESPANOLA
    65. Dauman, R; Daubech, Q; Gavilan, I; Colmet, L; Delaroche, M; Michas, N; Baldet, F; Saget, F; Diallo, A; Duriez, F; Olegaray, F; Soriano, V; Debruge, E
      Long-term outcome of childhood hearing deficiency

      ACTA OTO-LARYNGOLOGICA
    66. Perez-Olmeda, M; Gonzalez, J; Garcia-Samaniego, J; Arribas, JR; Soriano, V
      Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    67. Perez-Olmeda, M; Rubio, A; Puig, T; Gomez-Cano, M; Ruiz, L; Leal, M; Clotet, B; Soriano, V
      Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens

      ANTIVIRAL THERAPY
    68. Gomez-Cano, M; Rubio, A; Ruiz, L; Perez-Olmeda, M; Leal, M; Clotet, B; Soriano, V
      Efficiency of drug resistance genotypic tests in specimens with low HIV viral load

      ANTIVIRAL THERAPY
    69. Briones, C; Soriano, V
      Different outcome in the first two patients with an HIV-1 multinucleoside drug-resistant T69SSS insertion in Spain

      ANTIVIRAL THERAPY
    70. Lin, PF; Gonzalez, CJ; Griffith, B; Friedland, G; Calvez, V; Ferchal, F; Schinazi, RF; Shepp, DH; Ashraf, AB; Wainberg, MA; Soriano, V; Mellors, JW; Colonno, RJ
      Stavudine resistance: an update on susceptibility following prolonged therapy

      ANTIVIRAL THERAPY
    71. Rubio, A; Gomez-Cano, M; Puig, T; Leal, M; Perez-Olmeda, M; Ruiz, L; Clotet, B; Rey, C; Zamora, L; Xaus, N; Soriano, V
      Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral load

      ANTIVIRAL THERAPY
    72. Soriano, V
      Prevalence of drug resistance mutations in Spain among both naive and pretreated patients

      ANTIVIRAL THERAPY
    73. de Mendoza, C; Soriano, V; Perez-Olmeda, M; Rodes, B; Casas, E; Gonzalez-Lahoz, J
      Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy

      JOURNAL OF HUMAN VIROLOGY
    74. Fernandez, J; Blanca, M; Soriano, V; Sanchez, J; Juarez, C
      Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area

      CLINICAL AND EXPERIMENTAL ALLERGY
    75. Rodriguez-Rosado, R; Soriano, V; Blanco, F; Dona, C; Gonzalez-Lahoz, J
      Diabetes mellitus associated with protease inhibitor use

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    76. de Mendoza, C; Soriano, V; Gonzalez-Lahoz, J
      Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    77. Perez-Olmeda, M; Rodriguez-Rosado, R; Gomez-Cano, M; Briones, C; Soriano, V
      Usefulness of genotypic analysis of resistance to nucleoside analogues in the clinical setting

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    78. Villalba, N; Gomez-Cano, M; Holguin, A; Soriano, V
      Multiple drug resistance genotype causing failure of antiretroviral treatment in an HIV-infected patient heavily exposed to nucleoside analogues

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    79. Villalba, N; Perez-Olmeda, M; de Jose, M; Hernandez, M; Sirera, R; Espanol, T; Gonzalez-Molina, A; Soriano, V
      CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    80. Holguin, A; de Mendoza, C; Soriano, V
      Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    81. Soriano, V; Machuca, A; Gutierrez, M
      Human T-cell leukemia/lymphoma virus type II infection in Spain

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    82. Mas, A; Quinones-Mateu, ME; Domingo, E; Soriano, V
      Phylogeny of HIV type 1 group O isolates based on env gene sequences

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    83. Soriano, V; Garcia-Samaniego, J; Valencia, E; Rodriguez-Rosado, R; Munoz, F; Gonzalez-Lahoz, J
      Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users

      EUROPEAN JOURNAL OF EPIDEMIOLOGY
    84. Machuca, A; Soriano, V; Gutierrez, M; Holguin, A; Aguilera, A; Caballero, E; Cilla, G
      Human immunodeficiency virus type 2 infection in Spain

      INTERVIROLOGY
    85. Rodriguez-Rosado, R; Briones, C; Soriano, V
      Introduction of HIV drug-resistance testing in clinical practice

      AIDS
    86. de Mendoza, C; Soriano, V; Rodriguez-Rosado, R; Gonzalez-Lahoz, J
      Higher antiviral activity of antiretroviral regimens including protease inhibitors

      AIDS
    87. Soriano, V; Rodriguez-Rosado, R; Garcia-Samaniego, J
      Management of chronic hepatitis C in HIV-infected patients

      AIDS
    88. Anton, P; Soriano, V; Jimenez-Nacher, I; Rodriguez-Rosado, R; Dona, MC; Barreiro, PM; Gonzalez-Lahoz, J
      Incidence of rash and discontinuation of nevirapine using two different escalating initial doses

      AIDS
    89. Barreiro, PM; Dona, MC; Castilla, J; Soriano, V
      Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy

      AIDS
    90. Vallejo, A; Mas, A; Heredia, A; Altisent, C; Lorenzo, I; Soriano, V; Hewlett, IK
      V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohortwith long-term non-progressive infection

      AIDS
    91. Rodriguez-Rosado, R; Soriano, V; Barreiro, P; Dona, C; Gonzalez-Lahoz, J
      What dual protease inhibitor combination for salvage therapies?

      AIDS
    92. Ledesma, E; Soriano, V
      Spanish consensus conference on drug resistance testing in clinical practice

      AIDS
    93. Gordillo, V; del Amo, J; Soriano, V; Gonzalez-Lahoz, J
      Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

      AIDS
    94. Marcellin, P; Alberti, A; Dusheiko, G; Esteban, R; Manns, M; Shouval, D; Weiland, O; Williams, R; Benhamou, JP; Rodes, J; Alter, H; Bismuth, H; Desmet, V; Guardia, J; Heathcote, J; Lok, A; Maddrey, WC; Zum Buschenfelde, KHM; Pagliaro, L; Paumgartner, G; Sherlock, S; Abrignani, S; Alberti, A; Alter, M; Bonino, F; Bortolotti, F; Brechot, C; de Moura, MC; Carreno, V; Colombo, M; Craxi, A; Davis, G; De Francesco, R; Degos, F; Di Bisceglie, A; Dienes, H; Dusheiko, G; Esteban, J; Esteban, R; Farci, P; Ferrari, C; Foster, G; Hadziyannis, S; Hoofnagle, J; Koff, R; Lavanchy, D; Lindsay, K; Lunel, F; Manns, M; Marcellin, P; Mondelli, M; Nalpas, B; Naoumov, N; Pawlotsky, JM; Pol, S; Pontisso, P; Poynard, T; Prieto, J; Rizzetto, M; Roggendorf, M; Moreno, MR; Samuel, D; Sanchez-Tapias, J; Schalm, S; Shouval, D; Simmonds, P; Soriano, V; Tassopoulos, N; Thomas, H; Trepo, C; Van der Poel, CL; Vogel, W; Weiland, O; Wejstal, R; Williams, R; Wright, T; Zanetti, A; Zarski, JP; Zeuzem, S; Zoulim, F
      EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999)

      JOURNAL OF HEPATOLOGY
    95. Soriano, V; Garcia-Samaniego, J; Rodriguez-Rosado, R; Gonzalez, J; Pedreira, J
      Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

      JOURNAL OF HEPATOLOGY
    96. Mas, A; Espanol, T; Heredia, A; Pedraza, MA; Hernandez, M; Caragol, I; Fernando, M; Bertran, JM; Alcami, J; Soriano, V
      CCR5 genotype and HIV-1 infection in perinatally-exposed infants

      JOURNAL OF INFECTION
    97. Holguin, A; Rodes, B; Dietrich, U; Soriano, V
      Human immunodeficiency viruses type I subtypes circulating in Spain

      JOURNAL OF MEDICAL VIROLOGY
    98. Abrams, D; Allan, D; Antunes, F; Breckenridge, A; Bruun, J; Cameron, W; Carbon, C; Chalmers, I; Chang, H; Chodakewitz, J; Clendenin, N; Clumeck, N; Collier, A; Collins, G; Cooper, E; Cooper, D; Danner, S; D'Aquila, R; DeGruttola, V; DeMasi, R; Dee, L; Deyton, L; Dixon, D; Farthing, C; Feinberg, J; Fischl, M; Flepp, M; Gartland, M; Gatell, J; Gazzard, B; Goebel, F; Gotzsche, P; Gringeri, A; Hall, D; Hamilton, J; Hammer, S; Hartigan, P; Heath-Chiozzi, M; Henry, K; Hill, A; Hirschel, B; Ioannidis, J; Kahn, J; Katlama, C; Katzenstein, D; Killen, J; King, E; de Loes, SK; Kravcik, S; Lange, J; Leavitt, R; Leonard, J; Maeland, A; Mannucci, P; Mathiesen, L; McDade, H; Meibohn, A; Melander, H; Merigan, T; Mulder, J; Myers, M; Neaton, J; Nessling, M; Perrin, L; Pettinelli, C; Phair, J; Phillips, A; Pinching, A; Poppa, A; Power, L; Reiss, P; Richman, D; Rooney, J; Rousseau, F; Rutherford, G; Salgo, M; Sandstrom, E; Saravolatz, L; Savidge, G; Schnittman, S; Schooley, R; Seligmann, M; Simberkoff, M; Skowron, G; Slade, P; Smith, D; Smith, RP; Soriano, V; Stanley, K; Stingl, G; Stoffels, P; Struthers, L; Tierney, C; Thompson, M; Van der Broeck, R; Van Leeuven, R; Van Weverling, G; Veenstra, J; Vella, S; Volberding, P; Weber, J; Winslow, D; Yeni, P; Yeo, J; Dormont, J; Sande, M; Weller, I; Babiker, A; Collins, R; Darbyshire, J; Duncan, W; Foulkes, M; Hughes, M; Peto, R; Peto, T; Walker, S
      Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence

      LANCET
    99. Lerma, JGG; Schinazi, RF; Juodawlkis, AS; Soriano, V; Lin, YL; Tatti, K; Rimland, D; Folks, TM; Heneine, W
      A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    100. de la Fuente, L; Bravo, MJ; Lew, C; Barrio, G; Soriano, V; Royuela, L
      Prevalence of HIV infection and risk habits in heroin takers of Barcelona,Madrid and Sevilla (Spain). An example of the advantages of focusing studies on drug-takers in spite of intravenous drug users

      MEDICINA CLINICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 05:16:32